PRKCI and ovarian serous adenocarcinoma: Bioinformatics analysis showed that ECT2, as a part of the 3q26 amplicon, co-amplified and overexpressed with (protein kinase C iota) PRKCI, and other molecules in ovarian serous cancer (Callebaut and Mornon, 1997; Wang et al., 2013).